Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leiomyosarcoma Uterus”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00005643
What this trial is testing

Chemotherapy in Treating Patients With Sarcoma of the Uterus

Who this might be right for
Endometrial CancerSarcoma
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT04811196
What this trial is testing

Different Dosing Schedules of Selinexor in Sarcoma Patients

Who this might be right for
Soft Tissue SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Leiomyosarcoma+1 more
University Health Network, Toronto 56
Testing effectiveness (Phase 2)Study completedNCT00390234
What this trial is testing

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT04727242
What this trial is testing

CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

Who this might be right for
LMS - LeiomyosarcomaUterine Leiomyosarcoma
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT01220609
What this trial is testing

Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00245102
What this trial is testing

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more
National Cancer Institute (NCI) 147
Testing effectiveness (Phase 2)WithdrawnNCT02378142
What this trial is testing

Pazopanib for Treating Uterine Leiomyosarcoma

Who this might be right for
Uterine Leiomyosarcoma
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00006005
What this trial is testing

Thalidomide in Treating Patients With Gynecologic Sarcomas

Who this might be right for
Endometrial CancerSarcoma
New York University Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Large-scale testing (Phase 3)Study completedNCT00002459
What this trial is testing

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus

Who this might be right for
Endometrial CancerSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 224
Testing effectiveness (Phase 2)Study completedNCT02131480
What this trial is testing

Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma

Who this might be right for
Uterus LeiomyosarcomaSoft Tissue Leiomyosarcoma
Gustave Roussy, Cancer Campus, Grand Paris 110
Not applicableUnknownNCT04214457
What this trial is testing

Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas

Who this might be right for
LeiomyomaLeiomyosarcoma
Igenomix 1,000
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Active Not RecruitingNCT03880019
What this trial is testing

A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

Who this might be right for
Stage III Uterine Corpus Leiomyosarcoma AJCC v8Stage IV Uterine Corpus Leiomyosarcoma AJCC v8Uterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00856050
What this trial is testing

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Dana-Farber Cancer Institute 27
Testing effectiveness (Phase 2)Ended earlyNCT00003316
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Not applicableStudy completedNCT06678763
What this trial is testing

Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS

Who this might be right for
Uterine Leiomyosarcoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 19
Next Page